SG11201506810RA - Method of treatment - Google Patents

Method of treatment

Info

Publication number: SG11201506810RA
Authority: SG; Singapore
Prior art keywords: treatment
Prior art date: 2013-03-18

Application number

SG11201506810RA

Other languages

English (en)

Inventor

Yaela Baine

Jacqueline Miller

Original Assignee

Glaxosmithkline Biolog Sa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2013-03-18

Filing date

2014-03-17

Publication date

2015-10-29

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=50336313&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SG11201506810R(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2014-03-17 Application filed by Glaxosmithkline Biolog Sa filed Critical Glaxosmithkline Biolog Sa

2015-10-29 Publication of SG11201506810RA publication Critical patent/SG11201506810RA/en

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/095—Neisseria
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/6037—Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Immunology (AREA)
Microbiology (AREA)
Mycology (AREA)
Epidemiology (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Virology (AREA)

SG11201506810RA 2013-03-18 2014-03-17 Method of treatment SG11201506810RA (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US201361802918P	2013-03-18	2013-03-18
US201361874008P	2013-09-05	2013-09-05
PCT/EP2014/055355 WO2014147044A1 (fr)	2013-03-18	2014-03-17	Procédé de traitement

Publications (1)

Publication Number	Publication Date
SG11201506810RA true SG11201506810RA (en)	2015-10-29

Family

ID=50336313

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
SG10201710137QA SG10201710137QA (en)	2013-03-18	2014-03-17	Method of treatment
SG11201506810RA SG11201506810RA (en)	2013-03-18	2014-03-17	Method of treatment

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
SG10201710137QA SG10201710137QA (en)	2013-03-18	2014-03-17	Method of treatment

Country Status (21)

Country	Link
US (1)	US11883478B2 (fr)
EP (1)	EP2976101B1 (fr)
JP (2)	JP6747968B2 (fr)
KR (1)	KR20150121265A (fr)
CN (1)	CN105188743A (fr)
AU (1)	AU2014234408B2 (fr)
BE (1)	BE1021934B1 (fr)
BR (1)	BR112015024014A2 (fr)
CA (1)	CA2903322C (fr)
CY (1)	CY1123600T1 (fr)
DK (1)	DK2976101T3 (fr)
EA (1)	EA034380B1 (fr)
ES (1)	ES2830035T3 (fr)
HU (1)	HUE051592T2 (fr)
IL (1)	IL241096B (fr)
MX (1)	MX382165B (fr)
PL (1)	PL2976101T3 (fr)
PT (1)	PT2976101T (fr)
SG (2)	SG10201710137QA (fr)
SI (1)	SI2976101T1 (fr)
WO (1)	WO2014147044A1 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
HRP20240433T1 (hr) *	2016-09-02	2024-07-05	Sanofi Pasteur, Inc.	Cjepivo protiv neisseria meningitidis
JP7311103B2 (ja) *	2017-11-06	2023-07-19	オーゼットキューピーティーワイリミテッド	ワクチン
CN110652585B (zh) *	2018-10-26	2023-05-26	武汉博沃生物科技有限公司	多糖-蛋白缀合物免疫制剂及其制备与应用
CA3161857A1 (fr) *	2019-11-22	2021-05-27	Glaxosmithkline Biologicals Sa	Dosage et administration d'un vaccin a base de glycoconjugue de saccharide bacterien

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7018637B2 (en)	1998-02-23	2006-03-28	Aventis Pasteur, Inc	Multi-oligosaccharide glycoconjugate bacterial meningitis vaccines
YU66103A (sh) *	2001-01-23	2006-05-25	Aventis Pasteur	Vakcina multivalentnog konjugata meningokokalnog polisaharid-proteina
GB0409745D0 (en) *	2004-04-30	2004-06-09	Chiron Srl	Compositions including unconjugated carrier proteins
US9789179B2 (en) *	2005-06-27	2017-10-17	Glaxosmithkline Biologicals S.A.	Immunogenic composition
AU2012203419B2 (en) *	2005-06-27	2014-06-26	Glaxosmithkline Biologicals S.A.	Immunogenic composition
CA2633789A1 (fr) *	2005-12-23	2007-06-28	Glaxosmithkline Biologicals Sa	Vaccin
ATE554788T1 (de)	2006-03-22	2012-05-15	Novartis Ag	Schemata zur immunisierung mit meningokokken- konjugaten

2014
- 2014-03-17 PT PT147112320T patent/PT2976101T/pt unknown
- 2014-03-17 CA CA2903322A patent/CA2903322C/fr active Active
- 2014-03-17 CN CN201480016792.XA patent/CN105188743A/zh active Pending
- 2014-03-17 AU AU2014234408A patent/AU2014234408B2/en active Active
- 2014-03-17 EA EA201591468A patent/EA034380B1/ru not_active IP Right Cessation
- 2014-03-17 DK DK14711232.0T patent/DK2976101T3/da active
- 2014-03-17 BE BE2014/0175A patent/BE1021934B1/fr active
- 2014-03-17 SI SI201431706T patent/SI2976101T1/sl unknown
- 2014-03-17 HU HUE14711232A patent/HUE051592T2/hu unknown
- 2014-03-17 WO PCT/EP2014/055355 patent/WO2014147044A1/fr active Application Filing
- 2014-03-17 JP JP2016503631A patent/JP6747968B2/ja active Active
- 2014-03-17 SG SG10201710137QA patent/SG10201710137QA/en unknown
- 2014-03-17 SG SG11201506810RA patent/SG11201506810RA/en unknown
- 2014-03-17 KR KR1020157030027A patent/KR20150121265A/ko not_active Ceased
- 2014-03-17 MX MX2015013401A patent/MX382165B/es unknown
- 2014-03-17 EP EP14711232.0A patent/EP2976101B1/fr not_active Revoked
- 2014-03-17 US US14/777,985 patent/US11883478B2/en active Active
- 2014-03-17 PL PL14711232T patent/PL2976101T3/pl unknown
- 2014-03-17 BR BR112015024014A patent/BR112015024014A2/pt not_active Application Discontinuation
- 2014-03-17 ES ES14711232T patent/ES2830035T3/es active Active
2015
- 2015-09-03 IL IL241096A patent/IL241096B/en active IP Right Grant
2019
- 2019-04-04 JP JP2019072050A patent/JP2019142898A/ja active Pending
2020
- 2020-11-19 CY CY20201101097T patent/CY1123600T1/el unknown

Also Published As

Publication number	Publication date
KR20150121265A (ko)	2015-10-28
US11883478B2 (en)	2024-01-30
JP2016515539A (ja)	2016-05-30
JP6747968B2 (ja)	2020-08-26
CA2903322C (fr)	2023-09-05
CY1123600T1 (el)	2022-03-24
HUE051592T2 (hu)	2021-03-01
SG10201710137QA (en)	2018-01-30
IL241096B (en)	2021-05-31
BR112015024014A2 (pt)	2017-07-18
PT2976101T (pt)	2020-11-12
IL241096A0 (en)	2015-11-30
EP2976101A1 (fr)	2016-01-27
US20160279225A1 (en)	2016-09-29
EA201591468A1 (ru)	2016-04-29
CN105188743A (zh)	2015-12-23
MX2015013401A (es)	2016-01-08
MX382165B (es)	2025-03-13
AU2014234408A1 (en)	2015-10-22
AU2014234408B2 (en)	2017-04-20
EA034380B1 (ru)	2020-01-31
DK2976101T3 (da)	2020-11-23
PL2976101T3 (pl)	2021-03-08
CA2903322A1 (fr)	2014-09-25
BE1021934B1 (fr)	2016-01-27
EP2976101B1 (fr)	2020-08-19
ES2830035T3 (es)	2021-06-02
SI2976101T1 (sl)	2021-01-29
JP2019142898A (ja)	2019-08-29
WO2014147044A1 (fr)	2014-09-25

Publication	Publication Date	Title
ZA201505956B (en)	2016-11-30	Methods of treating melanoma
GB201401248D0 (en)	2014-03-12	Method of manufacture
ZA201506534B (en)	2017-11-29	Method of treating hair
SG11201508878WA (en)	2015-11-27	Methods of treating cancer
GB201304872D0 (en)	2013-05-01	Treatment
IL242678B (en)	2021-08-31	A method for treating intracellular infection
GB201308466D0 (en)	2013-06-19	Improved process for treatment of minewater
ZA201507475B (en)	2017-02-22	Method for the treatment of gas
ZA201507762B (en)	2017-09-27	Methods of treating cancer
GB201305231D0 (en)	2013-05-01	Method of Manufacture
IL241096A0 (en)	2015-11-30	Treatment methods
GB2518928B (en)	2017-03-01	Method of depilation
PL3082860T3 (pl)	2021-06-14	Sposób leczenia ran
EP2985265A4 (fr)	2016-12-28	Procédé de traitement d'eaux résiduelles
GB201307310D0 (en)	2013-05-29	Treatment
ZA201601626B (en)	2017-05-31	Treatment of gases
PL3041506T3 (pl)	2023-05-15	Sposób leczenia
SG11201602010VA (en)	2016-04-28	Heat treatment method
GB201322778D0 (en)	2014-02-05	Method of treatment
GB201314882D0 (en)	2013-10-02	Method of treatment
AU2013904712A0 (en)	2013-12-19	Method of Treatment
AU2013904170A0 (en)	2013-11-14	Method of treatment
IL245100A0 (en)	2016-06-30	Methods for treating stomatitis associated with m-tor inhibitors
AU2013901359A0 (en)	2013-05-09	Methods of Treatment
GB201311291D0 (en)	2013-08-14	Method of manufacture